Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a pseudogene annotated as "signal peptide peptidase-like 3 pseudogene" (also known as LOC100132647 and ENSG00000263733). It is not a protein-coding gene and does not produce a functional protein. As a result, it is not considered a valid biological or therapeutic target and has no established role in physiology, pathology, or medicine. This pseudogene designation distinguishes it from the functional gene "Signal peptide peptidase like 3" (SPPL3), which does encode an intramembrane-cleaving aspartyl protease involved in glycan modification and immune signaling. The pseudogene, however, does not produce active protein and thus does not share these properties or clinical relevance. Databases associate LOC100132647 only with pseudogene status, not with protein expression or biological function. The confusion can arise due to the near identity in name to SPPL3, a well-studied protein-coding gene, but LOC100132647 (ENSG00000263733) is definitively annotated as a pseudogene, not as the active enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptide peptidase-like 3 pseudogene.